These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11226641)

  • 1. Integrity of the blood-cerebrospinal fluid barrier in early Parkinson's disease.
    Haussermann P; Kuhn W; Przuntek H; Muller T
    Neurosci Lett; 2001 Mar; 300(3):182-4. PubMed ID: 11226641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG.
    Frölich L; Kornhuber J; Ihl R; Fritze J; Maurer K; Riederer P
    Eur Arch Psychiatry Clin Neurosci; 1991; 240(6):363-6. PubMed ID: 1831668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation.
    Hampel H; Müller-Spahn F; Berger C; Haberl A; Ackenheil M; Hock C
    Dementia; 1995; 6(6):348-54. PubMed ID: 8563789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid indices of blood-brain barrier permeability following adrenal-brain transplantation in patients with Parkinson's disease.
    Ahlskog JE; Tyce GM; Kelly PJ; van Heerden JA; Stoddard SL; Carmichael SW
    Exp Neurol; 1989 Aug; 105(2):152-61. PubMed ID: 2753115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio.
    Blennow K; Fredman P; Wallin A; Gottfries CG; Långström G; Svennerholm L
    Eur Neurol; 1993; 33(2):126-8. PubMed ID: 8467818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction.
    Winfield JB; Shaw M; Silverman LM; Eisenberg RA; Wilson HA; Koffler D
    Am J Med; 1983 May; 74(5):837-44. PubMed ID: 6837607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets.
    Hampel H; Kötter HU; Möller HJ
    Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):78-87. PubMed ID: 9194954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum protein concentration gradients.
    Livrea P; Trojano M; Simone IL; Zimatore GB; Pisicchio L; Logroscino G; Cibelli G
    J Neurol Sci; 1984 Jun; 64(3):245-58. PubMed ID: 6206205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.
    Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A
    CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of cerebrospinal fluid protein assays in various neurologic diseases.
    Christenson RH; Behlmer P; Howard JF; Winfield JB; Silverman LM
    Clin Chem; 1983 Jun; 29(6):1028-30. PubMed ID: 6851088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligoclonal bands and blood--cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis.
    Hampel H; Kötter HU; Padberg F; Körschenhausen DA; Möller HJ
    Alzheimer Dis Assoc Disord; 1999 Jan; 13(1):9-19. PubMed ID: 10192637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein analysis in cerebrospinal fluid. III. Relation to blood-cerebrospinal fluid barrier function for formulas for quantitative determination of intrathecal IgG production.
    Blennow K; Fredman P; Wallin A; Gottfries CG; Skoog I; Wikkelsö C; Svennerholm L
    Eur Neurol; 1993; 33(2):134-42. PubMed ID: 8467820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal cerebrospinal fluid protein indices in schizophrenia.
    Kirch DG; Kaufmann CA; Papadopoulos NM; Martin B; Weinberger DR
    Biol Psychiatry; 1985 Oct; 20(10):1039-46. PubMed ID: 4041510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signs of impaired blood-brain barrier function and lower IgG synthesis within the central nervous system in patients with schizophrenia or related psychosis, compared to that in controls.
    Melkersson K; Bensing S
    Neuro Endocrinol Lett; 2018 Mar; 39(1):33-42. PubMed ID: 29803205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid.
    Vawter MP; Dillon-Carter O; Tourtellotte WW; Carvey P; Freed WJ
    Exp Neurol; 1996 Dec; 142(2):313-22. PubMed ID: 8934562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the concentrations of cerebrospinal fluid immunoglobulin G and albumin in children.
    Hung KL; Chang MT; Tsai ML; Chen WC
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(5):325-31. PubMed ID: 1296442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulas for the quantitation of intrathecal IgG production. Their validity in the presence of blood-brain barrier damage and their utility in multiple sclerosis.
    Blennow K; Fredman P; Wallin A; Gottfries CG; Frey H; Pirttilä T; Skoog I; Wikkelsö C; Svennerholm L
    J Neurol Sci; 1994 Jan; 121(1):90-6. PubMed ID: 8133315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment.
    Zetterberg H; Jakobsson J; Redsäter M; Andreasson U; Pålsson E; Ekman CJ; Sellgren C; Johansson AG; Blennow K; Landén M
    Psychiatry Res; 2014 Jul; 217(3):143-6. PubMed ID: 24745469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the minimal amount of IgG synthesized within the central nervous system in different neurological diseases.
    Kerényi L; Koltai M; Pálffy G
    Acta Med Acad Sci Hung; 1979; 36(4):367-73. PubMed ID: 122042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia.
    Kirch DG; Alexander RC; Suddath RL; Papadopoulos NM; Kaufmann CA; Daniel DG; Wyatt RJ
    J Neural Transm Gen Sect; 1992; 89(3):219-32. PubMed ID: 1389005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.